Disease & Vaccine Information

Who is at Highest Risk for Complications From Anthrax Vaccine?

Updated August 13, 2022


There is a gap in medical knowledge in terms of doctors being able to predict who will have an adverse reaction to anthrax vaccination, and who will not.

Women who receive the anthrax vaccine are at an increased risk of experiencing an adverse reaction.1

Biothrax anthrax vaccine is a Pregnancy Category D vaccine, which means that there is evidence of harm in human studies or fetal risk has been demonstrated in pre- or post-marketing surveillance data. Pregnant women who receive anthrax vaccine may be at high-risk of having an infant with birth defects.2 3

Persons with a history of latex sensitivity or previous allergic reaction to anthrax vaccine are a high risk of complications if administered anthrax vaccine.4


References:

[1] U.S. Centers for Disease Control and Prevention. Use of Anthrax Vaccine in the United States. MMWR Dec. 15, 2000; 49(RR15):1-20.

[2] Emergent BioDefense Operations Lansing LLC. Package Insert and Information for Patients – Biothrax. U.S. Food and Drug Administration Feb. 20, 2018.

[3] Johannes L. Anthrax Vaccine May Increase Incidence of Birth Defects for Pregnant Women. UCLA Department of Epidemiology School of Public Health Jan. 16, 2002.

[4] Emergent BioDefense Operations Lansing LLC. Package Insert and Information for Patients – Biothrax. U.S. Food and Drug Administration Feb. 20, 2018.

Opens in new tab, window
Opens an external site
Opens an external site in new tab, window